FrancophonIA/ELRC3.0 huggingface dataset:
English: The risk may increase in case of treatment combination with other medicinal products that may also provoke hyperkalaemia (salt substitutes containing potassium, potassiumsparing diuretics, ACE inhibitors, angiotensin II receptor antagonists, non steroidal antiinflammatory medicinal products (NSAIDs, including selective COX-2 inhibitors), heparin, immunosuppressives (cyclosporin or tacrolimus), and trimethoprim).
Estonian: See risk võib suureneda, kui seda kombineeritakse mõne muu samuti hüperkaleemiat esile kutsuda võiva ravimiga (kaaliumi sisaldavad soolaasendajad, kaaliumisäästvad diureetikumid, AKE inhibiitorid, angiotensiin II retseptori antagonistid, mittesteroidsed põletikuvastased ained (MSPVA-d, sh selektiivsed COX-2 inhibiitorid), hepariin, immunosupressandid (tsüklosporiin või takroliimus) ja trimetoprim).
English: Vascular disorders Uncommon:
Estonian: Vaskulaarsed häired Aeg-ajalt:
English: Respiratory, thoracic and mediastinal disorders Uncommon:
Estonian: Hüpotensioon, ortostaatiline hüpotensioon Respiratoorsed, rindkere ja mediastiinumi häired Aeg-ajalt:
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 40 mg telmisartan Excipients with known effect:
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS Üks tablett sisaldab 40 mg telmisartaani Teadaolevat toimet omav(ad) abiaine(d):
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 20 mg telmisartan Excipients with known effect:
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS Üks tablett sisaldab 20 mg telmisartaani Teadaolevat toimet omav(ad) abiaine(d):
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 80 mg telmisartan Excipients with known effect:
Estonian: KVALITATIIVNE JA KVANTITATIIVNE KOOSTIS Üks tablett sisaldab 80 mg telmisartaani Teadaolevat toimet omav(ad) abiaine(d):
English: Symptomatic hypotension, especially after the first dose of Telmisartan Teva, may occur in patients who are volume and/or sodium depleted by vigorous diuretic therapy, dietary salt restriction, diarrhoea, or vomiting.
Estonian: Patsientidel, kes saavad tugevat diureetilist ravi, on piiratud soolasisaldusega dieedil, kellel on kõhulahtisus või oksendamine, mille tagajärjel on välja kujunenud vedeliku- ja/või naatriumipuudus, võib Telmisartan Teva kasutamisel, eriti pärast esimest annust esineda sümptomaatiline hüpotensioon.
English: Corticosteroïds (systemic route) Reduction of the antihypertensive effect.
Estonian: Kortikosteroidid (süsteemselt)
English: Tell your doctor if you are breast-feeding or about to start breast-feeding.
Estonian: Kui te toidate last rinnaga või alustate rinnaga toitmist, rääkige sellest oma arstile.
English: Telmisartan Teva 80 mg tablets are white to off white, oval shaped tablets; one side of the tablet is debossed with the number "93".
Estonian: Telmisartan Teva 80 mg tabletid on valged kuni valkjad ovaalse kujuga tabletid; tableti ühele küljele on märgitud number „93“.
English: Telmisartan Teva 40 mg tablets are white to off white, oval shaped tablets; one side of the tablet is debossed with the number "93".
Estonian: Telmisartan Teva 40 mg tabletid on valged kuni valkjad ovaalse kujuga tabletid; tableti ühele küljele on märgitud number „93“.
English: potassium-sparing diuretics, ACE inhibitors, angiotensin II receptor antagonists, non steroidal antiinflammatory medicinal products (NSAIDs, including selective COX-2 inhibitors), heparin, immunosuppressives (cyclosporin or tacrolimus), and trimethoprim.
Estonian: mittesteroidsed põletikuvastased ained (MSPVA-d, sh selektiivsed COX-2 inhibiitorid), hepariin, immunosupressandid (tsüklosporiin või takroliimus) ja trimetoprim).
English: Prior treatment with high dose diuretics such as furosemide (loop diuretic) and hydrochlorothiazide (thiazide diuretic) may result in volume depletion, and in a risk of hypotension when initiating therapy with telmisartan.
Estonian: Telmisartaanravi alustamisega võib kaasneda veremahu vähenemine ja hüpotensiooni riski suurenemine, kui eelnevalt on raviks kasutatud diureetikumide - nt furosemiidi (lingudiureetikum) ja hüdroklorotiasiidi (tiasiiddiureetikum) - suuri annuseid.
English: Telmisartan Teva 20 mg tablets are white to off white, oval shaped tablets; one side of the tablet is debossed with the number "93".
Estonian: Telmisartan Teva 20 mg tabletid on valged kuni valkjad ovaalse kujuga tabletid; tableti ühele küljele on märgitud number „93“.
English: The blood pressure lowering effect of telmisartan can be increased by concomitant use of other antihypertensive medicinal products.
Estonian: Teiste antihüpertensiivsete ravimite samaaegne kasutamine võib tugevdada telmisartaani vererõhku langetavat toimet.
English: If you get any side effects,talk to your doctor or pharmacist.
Estonian: Kui teil tekib ükskõik milline kõrvaltoime, pidage nõu oma arsti või apteekriga.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 40 mg telmisartan
Estonian: TOIMEAINE(TE) SISALDUS Üks tablett sisaldab 40 mg telmisartaani
English: Each Telmisartan Teva tablet contains 20 mg telmisartan.
Estonian: Üks Telmisartan Teva tablett sisaldab 20 mg telmisartaani.
English: Each Telmisartan Teva tablet contains 40 mg telmisartan.
Estonian: Üks Telmisartan Teva tablett sisaldab 40 mg telmisartaani.
English: Each Telmisartan Teva tablet contains 80 mg telmisartan.
Estonian: Üks Telmisartan Teva tablett sisaldab 80 mg telmisartaani.
English: There is an apparent trend to a dose relationship to a time to recovery of baseline systolic blood pressure (SBP).
Estonian: Esialgse süstoolse vererõhu (SVR) taastumise aeg omab ilmset tendentsi sõltuda annusest.
English: Back pain (e.g. sciatica), muscle spasms, myalgia
Estonian: 1 Makani H, Bangalore S, Desouza KA, Shah A, Messerli FH.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 20 mg telmisartan
Estonian: TOIMEAINE(TE) SISALDUS Üks tablett sisaldab 20 mg telmisartaani
English: NAME OF THE MEDICINAL PRODUCT Telmisartan Teva 40 mg tablets telmisartan
Estonian: RAVIMPREPARAADI NIMETUS Telmisartan Teva 40 mg tabletid telmisartanum
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 80 mg telmisartan
Estonian: TOIMEAINE(TE) SISALDUS Üks tablett sisaldab 80 mg telmisartaani
English: Telmisartan Teva should be used only with caution in patients with mild to moderate hepatic impairment.
Estonian: Kerge kuni mõõduka maksakahjustusega patsientidel tuleb Telmisartan Teva't kasutada ettevaatusega.
English: EU/1/09/610/051 Cartons of 14x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/052 Cartons of 28x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/053 Cartons of 30x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/054 Cartons of 40x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/055 Cartons of 56x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/056 Cartons of 60x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/057 Cartons of 84x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/058 Cartons of 90x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/059 Cartons of 98x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/060 Cartons of 100x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/062 Carton of 30 tablets in aluminium-aluminium blister
Estonian: EU/1/09/610/028 Karbid 90x1 tabletiga lahti kooritavates perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/029 Karbid 98x1 tabletiga lahti kooritavates perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/030 Karbid 100x1 tabletiga lahti kooritavates perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/051 Karbid 14x1 tabletiga perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/052 Karbid 28x1 tabletiga perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/053 Karbid 30x1 tabletiga perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/054 Karbid 40x1 tabletiga perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/055 Karbid 56x1 tabletiga perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/056 Karbid 60x1 tabletiga perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/057 Karbid 84x1 tabletiga perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/058 Karbid 90x1 tabletiga perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/059 Karbid 98x1 tabletiga perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/060 Karbid 100x1 tabletiga perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/062 Karp 30 tabletiga alumiinium-alumiinium blistris
English: NAME OF THE MEDICINAL PRODUCT Telmisartan Teva 80 mg tablets telmisartan
Estonian: RAVIMPREPARAADI NIMETUS Telmisartan Teva 80 mg tabletid telmisartanum
English: NAME OF THE MEDICINAL PRODUCT Telmisartan Teva 40 mg tablets
Estonian: RAVIMPREPARAADI NIMETUS Telmisartan Teva 40 mg tabletid
English: Hepatic function abnormal/liver disorder 3
Estonian: Maksafunktsiooni häire/maksa häire2
English: NAME OF THE MEDICINAL PRODUCT Telmisartan Teva 80 mg tablets
Estonian: RAVIMPREPARAADI NIMETUS Telmisartan Teva 80 mg tabletid
English: Somnolence
Estonian: Unisus
English: Blood and the lymphatic system disorders Uncommon
Estonian: Vere ja lümfisüsteemi häired Aeg-ajalt:
English: PC: SN: NN:
Estonian: SN:
English: EU/1/09/610/041 Cartons of 14x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/042 Cartons of 28x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/043 Cartons of 30x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/044 Cartons of 40x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/045 Cartons of 56x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/046 Cartons of 60x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/047 Cartons of 84x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/048 Cartons of 90x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/049 Cartons of 98x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/050 Cartons of 100x1 tablets in perforated unit-dose aluminium-aluminium blisters EU/1/09/610/061 Carton of 30 tablets in aluminium-aluminium blister
Estonian: EU/1/09/610/021 Karbid 14x1 tabletiga lahti kooritavates perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/022 Karbid 28x1 tabletiga lahti kooritavates perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/023 Karbid 30x1 tabletiga lahti kooritavates perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/024 Karbid 40x1 tabletiga lahti kooritavates perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/025 Karbid 56x1 tabletiga lahti kooritavates perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/026 Karbid 60x1 tabletiga lahti kooritavates perforeeritud üheannuselistes alumiinium-alumiinium blistrites EU/1/09/610/027 Karbid 84x1 tabletiga lahti kooritavates perforeeritud üheannuselistes alumiinium-alumiinium blistrites
English: Therefore, in these patients an approptiate blood glucose monitoring should be considered; a dose adjustment of insulin or antidiabetics may be required, when indicated.
Estonian: Vajalikuks võib osutuda insuliini või diabeedivastaste ravimite annuse kohandamine vastavate näidustuste olemasolul.
English: NAME OF THE MEDICINAL PRODUCT Telmisartan Teva 20 mg tablets
Estonian: RAVIMPREPARAADI NIMETUS Telmisartan Teva 20 mg tabletid
English: NAME OF THE MEDICINAL PRODUCT Telmisartan Teva 20 mg tablets telmisartan
Estonian: RAVIMPREPARAADI NIMETUS Telmisartan Teva 20 mg tabletid telmisartanum
English: EU/1/09/610/021 14x1 tablets EU/1/09/610/022 28x1 tablets EU/1/09/610/023 30x1 tablets EU/1/09/610/024 40x1 tablets EU/1/09/610/025 56x1 tablets EU/1/09/610/026 60x1 tablets EU/1/09/610/027 84x1 tablets EU/1/09/610/028 90x1 tablets EU/1/09/610/029 98x1 tablets EU/1/09/610/030 100x1 tablets
Estonian: EU/1/09/610/021 14x1 tabletti EU/1/09/610/022 28x1 tabletti EU/1/09/610/023 30x1 tabletti EU/1/09/610/024 40x1 tabletti EU/1/09/610/025 56x1 tabletti EU/1/09/610/026 60x1 tabletti EU/1/09/610/027 84x1 tabletti EU/1/09/610/028 90x1 tabletti EU/1/09/610/029 98x1 tabletti EU/1/09/610/030 100x1 tabletti
English: EU/1/09/610/041 14x1 tablets EU/1/09/610/042 28x1 tablets EU/1/09/610/043 30x1 tablets EU/1/09/610/044 40x1 tablets EU/1/09/610/045 56x1 tablets EU/1/09/610/046 60x1 tablets EU/1/09/610/047 84x1 tablets EU/1/09/610/048 90x1 tablets EU/1/09/610/049 98x1 tablets EU/1/09/610/050
Estonian: EU/1/09/610/041 14x1 tabletti EU/1/09/610/042 28x1 tabletti EU/1/09/610/043 30x1 tabletti EU/1/09/610/044 40x1 tabletti EU/1/09/610/045 56x1 tabletti EU/1/09/610/046 60x1 tabletti EU/1/09/610/047 84x1 tabletti EU/1/09/610/048 90x1 tabletti EU/1/09/610/049 98x1 tabletti EU/1/09/610/050 100x1 tabletti EU/1/09/610/061 30 tabletti
English: EU/1/09/610/031 14x1 tablets EU/1/09/610/032 28x1 tablets EU/1/09/610/033 30x1 tablets EU/1/09/610/034 40x1 tablets EU/1/09/610/035 56x1 tablets EU/1/09/610/036 60x1 tablets EU/1/09/610/037 84x1 tablets EU/1/09/610/038 90x1 tablets EU/1/09/610/039 98x1 tablets EU/1/09/610/040 100x1 tablets
Estonian: EU/1/09/610/031 14x1 tabletti EU/1/09/610/032 28x1 tabletti EU/1/09/610/033 30x1 tabletti EU/1/09/610/034 40x1 tabletti EU/1/09/610/035 56x1 tabletti EU/1/09/610/036 60x1 tabletti EU/1/09/610/037 84x1 tabletti EU/1/09/610/038 90x1 tabletti EU/1/09/610/039 98x1 tabletti EU/1/09/610/040 100x1 tabletti
English: EU/1/09/610/011 14x1 tablets EU/1/09/610/012 28x1 tablets EU/1/09/610/013 30x1 tablets EU/1/09/610/014 40x1 tablets EU/1/09/610/015 56x1 tablets EU/1/09/610/016 60x1 tablets EU/1/09/610/017 84x1 tablets EU/1/09/610/018 90x1 tablets EU/1/09/610/019 98x1 tablets EU/1/09/610/020 100x1 tablets
Estonian: EU/1/09/610/011 14x1 tabletti EU/1/09/610/012 28x1 tabletti EU/1/09/610/013 30x1 tabletti EU/1/09/610/014 40x1 tabletti EU/1/09/610/015 56x1 tabletti EU/1/09/610/016 60x1 tabletti EU/1/09/610/017 84x1 tabletti EU/1/09/610/018 90x1 tabletti EU/1/09/610/019 98x1 tabletti EU/1/09/610/020 100x1 tabletti
English: EU/1/09/610/001 14x1 tablets EU/1/09/610/002 28x1 tablets EU/1/09/610/003 30x1 tablets EU/1/09/610/004 40x1 tablets EU/1/09/610/005 56x1 tablets EU/1/09/610/006 60x1 tablets EU/1/09/610/007 84x1 tablets EU/1/09/610/008 90x1 tablets EU/1/09/610/009 98x1 tablets EU/1/09/610/010 100x1 tablets
Estonian: EU/1/09/610/001 14x1 tabletti EU/1/09/610/002 28x1 tabletti EU/1/09/610/003 30x1 tabletti EU/1/09/610/004 40x1 tabletti EU/1/09/610/005 56x1 tabletti EU/1/09/610/006 60x1 tabletti EU/1/09/610/007 84x1 tabletti EU/1/09/610/008 90x1 tabletti EU/1/09/610/009 98x1 tabletti EU/1/09/610/010 100x1 tabletti
English: EU/1/09/610/051 14x1 tablets EU/1/09/610/052 28x1 tablets EU/1/09/610/053 30x1 tablets EU/1/09/610/054 40x1 tablets EU/1/09/610/055 56x1 tablets EU/1/09/610/056 60x1 tablets EU/1/09/610/057 84x1 tablets EU/1/09/610/058 90x1 tablets EU/1/09/610/059 98x1 tablets EU/1/09/610/060
Estonian: EU/1/09/610/051 14x1 tabletti EU/1/09/610/052 28x1 tabletti EU/1/09/610/053 30x1 tabletti EU/1/09/610/054 40x1 tabletti EU/1/09/610/055 56x1 tabletti EU/1/09/610/056 60x1 tabletti EU/1/09/610/057 84x1 tabletti EU/1/09/610/058 90x1 tabletti EU/1/09/610/059 98x1 tabletti EU/1/09/610/060 100x1 tabletti EU/1/09/610/062 30 tabletti
English: Pruritus, hyperhidrosis, rash
Estonian: Kihelus, liighigistamine, lööve
English: Muscoloskeletal and connective tissue disorders Uncommon:
Estonian: Maksa- ja sapiteede häired Harv:
English: Summary of the safety profile
Estonian: 1 - Ravimiohutuse riskihindamise nõuandekomitee teadusliku hindamise üldkokkuvõte
English: Metabolism and nutrition disorders Uncommon
Estonian: Ainevahetus- ja toitumishäired Aeg-ajalt:
English: 36 months
Estonian: 36 kuud
English: Other trials gave similar or higher results.
Estonian: Teised uuringud andsid samasuguseid või kõrgemaid tulemusi.
English: Tell your doctor promptly about these symptoms.
Estonian: Rääkige neist sümptomitest kohe arstile.
English: In rare instances, these cases were associated with swelling of the entire limb.
Estonian: Harvadel juhtudel olid need juhud seotud kogu jäseme tursega.
English: Not applicable.
Estonian: Ei ole kohaldatav
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION October 23
Estonian: ESMASE MÜÜGILOA VÄLJASTAMISE/MÜÜGILOA UUENDAMISE KUUPÄEV 23. oktoober 2000
English: Official batch release: in accordance with Article 114 Directive 2001/83/EEC, the official batch release will be undertaken by a state laboratory or a laboratory designated for that purpose.
Estonian: Partii ametlik vabastamine: vastavalt direktiivi 2001/83/EÜ artiklile 114 toimub partii ametlik vabastamine riikliku laboratooriumi või selleks eesmärgiks määratud laboratooriumi poolt.
English: Antipyretic treatment should be initiated according to local guidelines.
Estonian: Palavikuvastast ravi tuleb alustada vastavalt kohalikele juhistele.
English: Possible side effects 5.
Estonian: Võimalikud kõrvaltoimed 5.
English: Very rare (<1/10,000)
Estonian: Väga harv (<1/10,000)
English: Sumneytown Pike West Point
Estonian: Sumneytown Pike
English: It has been shown that PTxd and FHA play a major role in protection against pertussis.
Estonian: On tõestatud, et PTxd-l ja FHA-l on läkaköha vastases kaitses oluline roll.
English: The FHA is not detoxified.
Estonian: FHA ei ole detoksifitseeritud.
English: They were mostly mild, generally lasting for up to 72 hours and resolved spontaneously.
Estonian: Need olid enamasti kerged, kestsid tavaliselt kuni 72 tundi ja kadusid spontaanselt.
English: If the condition persists or worsens, you may have to bring your child to the doctor.
Estonian: Kui seisund püsib või halveneb, võib osutuda vajalikuks tuua laps arsti juurde.
English: * As lower confidence limit (p = 0.95).
Estonian: * Alumine usalduspiir (p = 0,95).
English: Evaluation of pharmacokinetic properties is not required for vaccines.
Estonian: Vaktsiinide farmakokineetiliste omaduste hindamine ei ole nõutav.
English: Surveillance and antibody long term persistence studies are ongoing and will provide additional information in regards to the duration of protection.
Estonian: Järelkontroll ja antikehade pikaajalise püsimise uuringud kestavad ja annavad lisateavet kaitse kestuse kohta.
English: Rarely, the patient may have prolonged or abnormal crying.
Estonian: Harva võib patsient pikka aega või ebatavaliselt nutta.
English: if your child has fever or other illness, particularly a cough, cold or flu (vaccination should be delayed).
Estonian: kui teie lapsel on palavik või muu haigus, eriti köha, külmetus või gripp (vaktsineerimine tuleb edasi lükata).
English: Primary vaccination :
Estonian: Esmane vaktsineerimine:
English: These reactions were mostly moderate and transient.
Estonian: Need reaktsioonid olid enamasti mõõdukad ja mööduva iseloomuga.
English: Pennsylvania 19486 USA
Estonian: West Point, Pennsylvania 19486, USA
English: Do not use after the expiry date stated on the label.
Estonian: Mitte kasutada pärast etiketil märgitud kõlblikkusaja lõppu.
English: This vaccine should not be used in newborns, adolescents or adults.
Estonian: Seda vaktsiini ei tohi kasutada vastsündinutel, noorukitel ega täiskasvanutel.
English: Read all of this leaflet carefully before your child is vaccinated.
Estonian: Lugege kogu infoleht hoolikalt läbi, enne kui lasete oma last vaktsineerida.
English: This vaccine has been prescribed for your child and you should not pass it on to others.
Estonian: Vaktsiin on välja kirjutatud isiklikult teie lapsele ja seda ei tohi anda kellelegi teisele.
English: If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.
Estonian: Kui täheldate mistahes kõrvaltoimeid, mida ei ole loetletud selles infolehes, informeerige sellest oma arsti või apteekrit.
English: Not all pack sizes may be marketed.
Estonian: Kõik pakendi suuruseid ei ole märgitud.
English: Pharmacotherapeutic group: Bacterial and viral vaccines, combined, ATC code : J07CA
Estonian: Farmakoterapeutiline grupp: bakterite ja viiruste vastased vaktsiinid, kombineeritud, ATC-kood: J07CA
English: Temperature of ≥ 40.0 °C within 48 hours, not due to another identifiable cause.
Estonian: Palavik ≥40,0 °C 48 tunni jooksul, ilma muu tuvastatava põhjuseta.
English: In such cases it is recommended to postpone the vaccination until the end of the disease or treatment.
Estonian: Sellistel juhtudel on soovitatav vaktsineerimine edasi lükata tervenemiseni või ravi lõpuni.
English: If your child is due to be vaccinated with HEXAVAC and other vaccines simultaneously, please ask your doctor for further information.
Estonian: Kui teie last on ette nähtud vaktsineerida HEXAVAC'i ja teiste vaktsiinidega samaaegselt, küsige arstilt selle kohta lisateavet.
English: Vaccination should be postponed in the case of fever or acute disease.
Estonian: Vaktsineerimine tuleb edasi lükata palaviku või ägeda haigestumise korral.
English: Except in the case of immunosuppressive therapy (see 4.4 Special warnings and special precautions for use), no significant clinical interaction with other treatments or biological products has been documented.
Estonian: Välja arvatud immuunsupressivse ravi puhul (vt 4.4 Hoiatused ja ettevaatusabinõud kasutamisel), ei ole olulisi kliinilisi koostoimeid teiste ravimitega ega bioloogiliste preparaatidega dokumenteeritud.
English: These signs and symptoms usually occurred within 48 hours following the vaccination.
Estonian: Need nähud ja sümptomid tekkisid tavaliselt 48 tunni jooksul pärast vaktsineerimist.
English: in case of newborns, adolescents or adults.
Estonian: vastsündinutel, noorukitel ega täiskasvanutel.
English: The 4-fold increase in post immunisation titres is considered a sign of seroconversion of which the clinical significance is unknown in the absence of a serological correlate of protection.
Estonian: Immuniseerimisjärgsete tiitrite neljakordset tõusu loetakse serokonversiooni nähuks, mille kliiniline olulisus ei ole kaitse seroloogilise korrelaadi puudumisel teada.
English: If you have further questions, please ask your doctor or your pharmacist.
Estonian: Kui teil on lisaküsimusi, pidage palun nõu arsti või apteekriga.
English: These reactions were mostly moderate (less than or equal to 39° C) and transient.
Estonian: Need reaktsioonid olid enamasti mõõdukad (mitte üle 39 °C) ja mööduva iseloomuga.
English: Known hypersensitivity to any component of the vaccine or severe reaction after previous administration of the vaccine.
Estonian: Ülitundlikkus vaktsiini mistahes komponendi suhtes või tugev reaktsioon pärast vaktsiini eelmist manustamist.
English: Adjuvanted on aluminium hydroxide (0.3 mg)
Estonian: Adjuvanteeritud alumiiniumhüdroksiidiga (0,3 mg)
English: In these circumstances the vaccination course should be continued with vaccine not containing a pertussis component.
Estonian: Neil juhtudel tuleb vaktsineerimiskuuri jätkata vaktsiiniga, mis ei sisalda läkaköha komponenti.
English: Using other vaccines
Estonian: Kasutamine koos teiste vaktsiinidega:
English: As with other hepatitis B vaccines, in many instances, the causal relationship to the vaccine has not been established.
Estonian: Nagu teistegi hepatiit B vaktsiinide puhul, ei ole paljudel juhtudel põhjuslikku seost vaktsiiniga kindlaks määratud.
English: HEXAVAC should under no circumstances be administered intravascularly.
Estonian: HEXAVAC'i ei tohi mitte mingil juhul manustada intravasaalselt.
English: • Post marketing experience
Estonian: • Turustamis järgsed kogemused
English: If you forget to take HEXAVAC: Your doctor will decide when to give the missed dose.
Estonian: Kui te olete unustanud HEXAVAC'iga vaktsineerimise: Arst otsustab, millal vahelejäänud annus anda.